Mirati Therapeutics Inc
Change company Symbol lookup
Select an option...
MRTX Mirati Therapeutics Inc
SIRC Solar Integrated Roofing Corp
CHSTY China High Speed Transmission Equipment Group Co Ltd
TTMZF Datable Technology Corp
WVFC W V S Financial Corp
WHLM Wilhelmina International Inc
SON Sonoco Products Co
VIRX Viracta Therapeutics Inc
PFS Provident Financial Services Inc
LPLA LPL Financial Holdings Inc
Go

Health Care : Biotechnology | Small Cap Growth
Company profile

Mirati Therapeutics Inc is a United States-based clinical-stage biotechnology company that is focused on bringing forward therapies that address areas of high unmet need, including lung cancer, and advancing a pipeline of novel therapeutics targeting the genetic and immunological drivers of cancer. The Company is using its scientific expertise to develop novel solutions in two registration-enabling programs: adagrasib (MRTX849), an investigational small molecule, potent and selective KRASG12C inhibitor, as monotherapy and in combination with other agents, and sitravatinib, an investigational spectrum-selective inhibitor of receptor tyrosine kinases in combination with checkpoint inhibitor therapies. The Company is also advancing its differentiated preclinical portfolio, including MRTX1133, an investigational KRASG12D inhibitor, MRTX1719, an investigational PRMT5 inhibitor, and other oncology discovery programs.

Premarket

Last Trade
Delayed
$70.06
-1.46 (-2.04%)
Bid
--
Ask
--
B/A Size
--

Market Hours

Closing Price
$71.52
Day's Change
0.00 (0.00%)
Bid close
--
Ask close
--
B/A Size
--
Day's High
--
Day's Low
--
Volume
(Light)
Volume:
222

10-day average volume:
2,168,695
222

Freeport-McMoRan Inc. Stock Outperforms Market Despite Losses On The Day

4:53 pm ET August 22, 2022 (MarketWatch)
Print

This article was automatically generated by MarketWatch using technology from Automated Insights.

Shares of Freeport-McMoRan Inc. (FCX) slipped 1.94% to $29.86 Monday, on what proved to be an all-around grim trading session for the stock market, with the S&P 500 Index falling 2.14% to 4,137.99 and Dow Jones Industrial Average falling 1.91% to 33,063.61. This was the stock's second consecutive day of losses. Freeport-McMoRan Inc. closed $22.13 below its 52-week high ($51.99), which the company reached on March 25th.

Trading volume (13.9 M) remained 7.3 million below its 50-day average volume of 21.2 M.

Data source: Dow Jones Market Data, FactSet. Data compiled August 22, 2022.

	

(END) Dow Jones Newswires

August 22, 2022 16:53 ET (20:53 GMT)

Copyright (c) 2022 Dow Jones & Company, Inc.

Earnings Calendar and Events Data provided by |Terms of Use| © 2022 Wall Street Horizon, Inc.

Market data accompanied by is delayed by at least 15 minutes for NASDAQ, NYSE MKT, NYSE, and options. Duration of the delay for other exchanges varies.
Market data and information provided by Morningstar.

Options are not suitable for all investors as the special risks inherent to options trading may expose investors to potentially rapid and substantial losses.
Please read Characteristics and Risks of Standard Options before investing in options.

Information and news provided by ,, , Computrade Systems, Inc., ,, and

Copyright © 2022. All rights reserved.